跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Albiomin - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Albiomin
Approved
STANDARD
Albiomin
Biotest Pharma GmbH
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
1ad31594e150cf69
Company
Biotest Pharma GmbH
Type
Standard
Approval Details
Approval Id
1ad31594e150cf69
Drug Approval Philippines Name
Albiomin
Product Name
Albiomin
Registration Number
BR-747
Brand Name
Albiomin
Generic Name
Human Albumin
Dosage Form
Solution for Injection for IV Infusion
Dosage Strength
20% (200 g/L)
Manufacturer
Biotest Pharma GmbH
Importer
EC Zuric Biotherapies, Inc.
Distributor
EC Zuric Biotherapies, Inc.
Company Detail Path
/organization/biotest-pharma-gmbh
Issuance Date
19 February 2021
Expiry Date
07 September 2025
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
1ad31594e150cf69
Type
Standard
Back to Philippines FDA Approvals